GilbertHin LungTangMDMSc, MBA, FRCSC

Adult Cardiac Surgery, Aortic Surgery, Minimally Invasive Cardiac Surgery, Cardiovascular Surgery

Assistant Professor, Westchester Medical Center, New York Medical College

Dr. Tang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1190 5th Ave
New York, NY 10029
Phone+1 212-659-6800

Fax+1 212-659-6818

PubMed

1 citations
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort.
Gilbert H L Tang, Rebecca T Hahn, Brian K Whisenant, Nadira Hamid, Hursh Naik
Journal of the American College of Cardiology. 2025-01-28
Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions: The THIRD Multicenter Registry.
Giuseppe Tarantini, Gilbert H L Tang, Thomas Pilgrim, Won-K Kim, Adam Greenbaum
JACC. Cardiovascular Interventions. 2025-01-13
In Vivo Frame Geometry of the Navitor Intra-Annular Self-Expanding Valve: A First-in-Human CT Analysis.
Gilbert H L Tang, Yusuke Kobari, Manish Vinayak, Parasuram Krishnamoorthy, Lucy M Safi
JACC. Cardiovascular Interventions. 2025-01-13

Lectures

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Neochord Transapical: Technology, FDA Pivotal Trial Updates (RECHORD), Progress With Transseptal Version
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Coronary Access and Coronary Obstruction: The Achilles' Heel of Redo TAVR?
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Transcatheter Leaflet Suspension for Primary MR
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Join now to see all

New Transcatheter Tricuspid Treatment Options Poised to Drive Surgical Volume GrowthJanuary 28th, 2025
Top Structural Heart News of 2024December 29th, 2024
Some Guidance for Managing Patients with AS and CAD: ReviewDecember 24th, 2024
Join now to see all